Q1 Earnings Forecast for LVTX Issued By HC Wainwright
LAVA Therapeutics (NASDAQ:LVTX – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for LAVA Therapeutics in a note issued to investors on Monday, March 31st. HC Wainwright analyst A. He expects that the company will post earnings per share of ($0.40) for the quarter. HC Wainwright […]
